FDA Inspection 947423 — Hunan Er-Kang Pharmaceutical Co., Ltd.

Hunan Er-Kang Pharmaceutical Co., Ltd. — FEI 3010165510

The FDA completed an inspection of Hunan Er-Kang Pharmaceutical Co., Ltd. on Sep 11, 2015 in Liuyang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 11, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liuyang (China)